← Explorer/Network

Intracellular localization of Borrelia burgdorferi within human endothelial cells

Ma Y, Sturrock A, Weis J1991Infection and ImmunityJournal Article
10.1128/iai.59.2.671-678.1991PubMedFree full text
CardiovascularImmune/InnateNeurological
Lyme & Co-Infections

Abstract

The later stages of infection by the Lyme disease pathogen, Borrelia burgdorferi, are characterized by the persistence of the organism in individuals possessing a strong anti-Borrelia immune response. This suggests that the organism is sequestered in a tissue protected from the immune system of the host or there is a reservoir of the organism residing within the cells of the host. In this report, the ability of B. burgdorferi to gain entrance into human umbilical vein endothelial cells was explored as a model for invasion. Incubation of B. burgdorferi with human umbilical vein endothelial cells at ratios ranging from 200:1 to 5,000:1 resulted in the intracellular localization of 10 to 25% of B. burgdorferi in 24 h. The intracellular location of the spirochetes was demonstrated by the incorporation of radiolabeled B. burgdorferi into a trypsin-resistant compartment and was confirmed by double-immunofluorescence staining which differentiated intracellular from extracellular organisms. Actin-containing microfilaments were required for the intracellular localization, indicating that the host cell participates in the internalization process. Activation of endothelial cells by agents known to increase the expression of several adhesion molecules had no effect on the interaction of B. burgdorferi with the endothelial monolayer. This indicates that the endothelial receptor for B. burgdorferi is constitutively expressed and that internalization is not dependent upon adhesion molecules whose expression is induced by inflammatory mediators. The demonstration of B. burgdorferi within endothelial cells suggest that intracellular localization may be a potential mechanism by which the organism escapes from the immune response of the host and may contribute to persistence of the organism during the later stages of Lyme disease.

Cited By (8)

  • Lyme disease: A neuropsychiatric illnessAmerican Journal of Psychiatry · 1994
  • Recurrent erythema migrans despite extended antibiotic treatment with minocycline in a patient with persisting Borrelia burgdorferi infectionJournal of the American Academy of Dermatology · 1993
  • Counterpoint: long-term antibiotic therapy improves persistent symptoms associated with Lyme diseaseClinical Infectious Diseases · 2007
  • Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory propertiesInfection and Immunity · 1993
  • Fibroblasts protect the Lyme disease spirochete, Borrelia burgdorferi, from ceftriaxone in vitroThe Journal of Infectious Diseases · 1992
  • Comparison of the Efficacy of Longer versus Shorter Pulsed High Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome with Bartonellosis and Associated CoinfectionsMicroorganisms · 2023

Related Papers

  • Herbal Therapeutics for CIRS Biomarkers in Autism Spectrum Disorders: A Mechanistic and Molecular Approach for Neuroimmune Pathology in PediatricsMedical Research Archives · 2025 · 4 shared tags
  • The Evolution of Chronic Inflammatory Response Syndrome (CIRS) and the Biotoxin Pathway2023 · 4 shared tags
  • Tick-borne relapsing feverSpringerReference · 2008 · 4 shared tags
  • Diversity and destruction of Borrelia hermsiiEmerg Infect Dis · 2007 · 4 shared tags
  • Tick-borne Relapsing Fever andBorrelia hermsii, Los Angeles County, California, USAEmerging infectious diseases · 2009 · 4 shared tags
  • Do babesiosis and malaria share a common disease processAnnals of Tropical Medicine and Parasitology · 1998 · 4 shared tags
Late-Stage Neuropsychiatric Lyme Borreliosis
Psychosomatics · 1995
  • Long term treatment of chronic Lyme arthritis with benzathine penicillinAnnals of the Rheumatic Diseases · 1992
  • References (1)

    • TREATMENT OF LATE LYME BORRELIOSIS—RANDOMISED COMPARISON OF CEFTRIAXONE AND PENICILLINThe Lancet · 1988